Inspire Medical Systems (INSP) insider reports 579-share tax withholding

Rhea-AI Filing Summary

Inspire Medical Systems, Inc. reported that officer Bryan K. Phillips had 579 shares of common stock withheld on a tax-withholding disposition related to the vesting of a restricted stock unit award. The shares were valued at $59.76 each, leaving him with 12,491 directly held shares afterward.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Phillips Bryan K

(Last) (First) (Middle)

C/O INSPIRE MEDICAL SYSTEMS, INC.

5500 WAYZATA BLVD., SUITE 1600

(Street)

GOLDEN VALLEY MN 55416

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Inspire Medical Systems, Inc. [ INSP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/13/2026		F		579(1)	D	$59.76	12,491	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award.

Remarks:

Senior Vice President, General Counsel, Secretary and Chief Compliance Officer. Exhibit 24 - Power of Attorney.

	/s/ Bryan Phillips	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did INSP’s Bryan K. Phillips report on this Form 4?

Bryan K. Phillips reported a tax-withholding disposition of 579 shares of Inspire Medical Systems common stock. The issuer withheld these shares to cover taxes due when a restricted stock unit award vested, rather than through an open-market sale.

Was the INSP Form 4 transaction an open-market sale of shares?

No, the transaction was not an open-market sale. The 579 shares of Inspire Medical Systems common stock were withheld by the issuer to satisfy tax obligations triggered by the vesting of a restricted stock unit award held by Bryan K. Phillips.

At what price were the 579 INSP shares valued in the tax-withholding transaction?

The 579 Inspire Medical Systems shares involved in the tax-withholding disposition were valued at $59.76 per share. This valuation is used for reporting and tax purposes when restricted stock units vest and shares are withheld to cover associated tax liabilities.

How many INSP shares does Bryan K. Phillips hold after this Form 4 transaction?

After the tax-withholding disposition, Bryan K. Phillips beneficially owns 12,491 shares of Inspire Medical Systems common stock directly. This figure reflects his holdings following the withholding of 579 shares to satisfy taxes on a vesting restricted stock unit award.

Why did Inspire Medical Systems withhold 579 shares from Bryan K. Phillips?

Inspire Medical Systems withheld 579 shares from Bryan K. Phillips to satisfy taxes due upon the vesting of a restricted stock unit award. This method allows the issuer to cover the tax liability by retaining shares instead of requiring a separate cash payment.